Funding: Massachusetts Alzheimer’s Disease Research Center (MADRC) 2021 Development Projects – November 13
Funding: Massachusetts Alzheimer’s Disease Research Center (MADRC) 2021 Development Projects
The Massachusetts Alzheimer’s Disease Research Center (MADRC) is pleased to announce a call for development research project proposals on Alzheimer’s disease (AD) and related dementias for funding expected to begin on April 1, 2021, contingent on NIA approval. The call is open to researchers from within the Harvard community, including the Harvard-affiliated hospitals and institutions, with priority given first to junior faculty, with consideration also given for senior researchers new to AD and related dementias research and finally, to established researchers with a new hypothesis, method or approach that is not an extension of ongoing AD research and which lacks funding. Applications from underrepresented groups are encouraged.
The purpose of the call is to allow an investigator the opportunity to develop preliminary data sufficient to provide the basis for an application for independent research support. Projects may range from basic or clinical biomedical to translational, epidemiological, caregiving, educational or behavioral research. Clinical trials are excluded, but development work in anticipation of a clinical trial will be accepted.
It is anticipated that 1-3 awards in the amount of up to $100,000 direct costs per project will be awarded for projects with a duration of one year. Facilities and administrative costs will be provided.